EDGAR 10-K Filing

Company CIK: 1554906
Filing Year: 2023
Filename: 1554906_10-K_2023_0001477932-23-007506.json

---

ITEM 1. BUSINESS
ITEM 1. BUSINESS
Corporate Background
Crown Baus Capital Corp. (“We” or the “Company”) was incorporated pursuant to the laws of the State of Nevada on August 8, 2011, as Flow Tech Solutions, Inc. We changed our name to World Stevia Corp. on August 15, 2013, then to Cannabis Capital Corp. on March 3, 2014, and finally to Crown Baus Capital Corp. on May 27, 2014.
Overview of Business and Operations
The Company’s mission is to work together with our shareholders, investors, and communities to create long-term value.
Our strategy is to identify companies in industries that complement the expertise of our management team, Board of Directors, and partners. Our management’s track record provides a highly attractive opportunity for prospective targets looking for proven value, liquidity, and capital procurement.
The Company is focused on becoming a global acquisitions-based company targeting high tech industries and financial services.
Employees
We have one executive who is a shareholder and currently contributes his time. The Company uses several consultants to assist in locating potential target companies and procure the financial resources required for the success of our business plan.
Government Regulation
We are currently not subject to any specific government regulation.
Subsidiaries
We do not have any subsidiaries.
Intellectual Property
We have no intellectual property other than own our domain address which signifies our online presence. Our trade name is our company name which is legally incorporated in the State of Nevada.

---

ITEM 1A. RISK FACTORS
ITEM 1A. RISK FACTORS
Smaller reporting companies are not required to provide disclosure pursuant to this Item.

---

ITEM 1B. UNRESOLVED STAFF COMMENTS
ITEM 1B. UNRESOLVED STAFF COMMENTS
As the Company is neither an accelerated filer nor a large, accelerated filer, as defined in Rule 12b-2 of the Exchange Act (§240.12b-2 of this chapter) or is a well-known seasoned issuer, the Company is not required to provide disclosure pursuant to this Item.

---

ITEM 2. PROPERTIES
ITEM 2. PROPERTIES
The Company’s office address is located at Suite 204 - 2383 King George Blvd, Surrey, British Columbia V4A5A4 Canada. The office space is contributed by our management.

---

ITEM 3. LEGAL PROCEEDINGS
ITEM 3. LEGAL PROCEEDINGS
None.

---

ITEM 4. MINE SAFETY DISCLOSURE
ITEM 4. MINE SAFETY DISCLOSURES
Not Applicable.
PART II

---

ITEM 5. MARKET FOR REGISTRANT'S COMMON EQUITY
ITEM 5. MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES
Market Information
The Company’s Common Stock trades on the OTC Markets platform under the symbol “CBCA”.
Price Range of Common Stock
The following information reflects the high and low bid prices of the Company’s common stock on the OTC Markets platform.
Quarterly period
High
Low
Fiscal year ended April 30, 2023:
First Quarter
$ .0002
$ .0002
Second Quarter
$ .0002
$ .0002
Third Quarter
$ .0002
$ .0002
Fourth Quarter
$ .0002
$ .0001
Fiscal year ended April 30, 2022:
First Quarter
$ .18
$ .0001
Second Quarter
$ .47
$ .0001
Third Quarter
$ .0001
$ .0001
Fourth Quarter
$ .0002
$ .0001
Common Stock
All outstanding shares of Common Stock are of the same class and have equal rights and attributes. The holders of Common Stock are entitled to one vote per share on all matters submitted to a vote of the Company’s stockholders. All stockholders are entitled to share equally in dividends, if any, as may be declared from time to time by the Board of Directors out of funds legally available. In the event of liquidation, the holders of Common Stock are entitled to share ratably in all assets remaining after payment of all liabilities. The stockholders do not have cumulative or preemptive rights.
Our transfer agent is Empire Stock Transfer. Their mailing address is 1859 Whitney Mesa Dr, Henderson, NV 89014.
The telephone and email address are (702)-818-5898 and casey@empirestock.com.
The description of certain matters relating to the securities of the Company is a summary and is qualified in its entirety by the provisions of the Company’s Certificate of Incorporation, as amended, and By-Laws.
Holders
As of the date of this filing we had approximately 60 shareholders of record of our common stock, including Cede and Co., which holds shares for the beneficial interest of an unknown number of stockholders in brokerage accounts.
Dividends
The Company has not paid any cash dividends to date and does not anticipate or contemplate paying dividends in the foreseeable future. It is the present intention of management to utilize all available funds for the development of the Company’s business.
Preferred Stock
The Company has issued 1,000 shares of Series A Convertible Preferred Stock with the following preferences. The shares vote as a class ay 50.1% on all business requiring a vote. The shares convert at the closing ask price on the day the conversion request is received by the Company at a stated value of $1,000 per preferred share
Stock Option/Warrant Grants
As of the date of this filing, the Company has no outstanding Option/Warrant grants.
Recent Sales of Unregistered Securities
100,000 common shares were sold at $.072 and will be issued when the required corporate financial filings are completed for the fiscal year ended 4/30/2023.

---

ITEM 6. SELECTED FINANCIAL DATA
ITEM 6. SELECTED FINANCIAL DATA
As a “smaller reporting company” as defined in Rule 12b-2 of Regulation S-K, the Company is not required to provide information required by Item 301 of Regulation S-K with respect to Selected Financial Data.

---

ITEM 7. MANAGEMENT'S DISCUSSION AND ANALYSIS
ITEM 7. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
Current Operations
Plan of Operations
The Company’s current plan of operations for the twelve months ending April 30, 2023, involved the continued development of the business plan.
Our ability to implement the phases of our business plan was dependent on us obtaining significant financing for these projects, which we were unable to secure during the year ending April 30, 2023.
Going Concern
We do not currently have any financing arranged and we cannot provide investors with any assurance that we will be able to raise sufficient funding from the sale of our common stock to fund further phases of our business plan. Even if we are successful in obtaining equity financing to fund our joint venture, there is no assurance that we will obtain the funding necessary to pay our creditors and noteholders on a timely basis. As a result, investors in our common stock would most likely lose all of their investments.
Results from Operations - For the years ended April 30, 2023, as compared to April 30, 2022 .
Operating results for the years ended April 30, 2023, and 2022 summarized as follows:
Years Ended April 30,
Revenue
$ -
$ -
Operating expenses
14,840
21,671
Other income (expense)
-
-
Net operating gain (loss)
$ (14,840 )
$ (21,671 )
Our net operating loss decreased $6,831 for the year ended April 30, 2023, from our year ended April 30, 2022. During the year ended April 30, 2023, our operating expenses decreased $6,831 from the year ended April 30, 2022. The decrease in expenses was mainly comprised of decreases in accounting fees and state fees with an increase in loan fees .
Liquidity and Capital Resources
As of April 30, 2023, we had cash of $5,351 and our working capital deficit was $240,844. In 2023, we generated revenues of $0 and a net loss of $14,840 from operations as compared to 2022 revenues of $0 and a net loss of $21,671.
The Company expects significant capital expenditure during the next 12 months, contingent upon raising additional capital. We anticipate that we will need a minimum of $2,000,000 for operations for the next 12 months.
The source of such capital is uncertain, and there is no assurance that the Company will be successful in obtaining such capital on commercially reasonable terms, or at all. We have a working capital deficit and will need cash infusions from investors and/or current shareholders to deploy our current business plan and joint venture.
To implement our business plan, we will need to continue to raise working capital in the form of equity in an amount up to $2,000,000 over the twelve-month period ending April 30, 2023, on terms and conditions to be determined. If we were unable to raise any funds from the sale of equity, management may elect to seek subsequent interim or “bridge” financing in the form of debt as may be necessary.
At this time, management is unable to determine the specific amounts and terms of such future financing, or whether or not we will be successful in raising such funds on a basis acceptable to us.
In order to finance the operations of the Company during the twelve months ending April 30, 2023, and 2022, the Company’s management and/or shareholders entered a series of note transactions or accounts payable totaling $0 and $0, respectively. We successfully raised $27,471 from notes payable and a stock subscription agreement.
Cash Flow
Years Ended
April 30,
Net cash provided (used) in operating activities
$ (97,286 )
$ (5,637 )
Net cash used in investing
-
-
Net cash provided (used) by financing activities
102,578
4,671
Net increase (decrease) in cash
$ 5,292
$ (966 )
Cash used in operating activities for years ended April 30, 2023, and 2022 was primarily for expenses related to general operations and for Company incurred administrative expenses.
Going Concern
Management believes that our current financial condition, liquidity, and capital resources will not satisfy our cash requirements for the next twelve months to deploy our current business plan, and as such we will need to either raise additional proceeds through financing facilities, sales of securities and our officers and directors will need to make additional financial commitments to our Company, neither of which is guaranteed. We plan to satisfy our future cash requirements, primarily the working capital required to execute on our current business and fund our necessary operating expenses, through financial commitments from future debt facilities and equity sales, if and when possible.
Management believes that we may generate some revenues within the next 12 months of 2023, but that these revenues will not satisfy our cash requirements to implement our current business plan, which is subject to change depending upon pending business opportunities and available financing.
We had no committed source for funds as of April 30, 2023, other than our convertible debt instruments. No representation is made that any funds will be available when needed. In the event that funds cannot be raised when needed, we may not be able to carry out our business plan, may never achieve revenue, and could fail to satisfy our future cash requirements as a result of these uncertainties.
It will be necessary to raise working capital funds through equity and debt financing facilities, which are extremely difficult for a developmental stage company to secure and may not be available to us or on a basis favorable to us. However, if such debt financing is available, we would likely have to pay additional costs associated with high-risk loans and be subject to above market interest rates.
The Company accumulated a deficit of $47,063,977 on April 30, 2023. We currently have only limited working capital with which to continue our operating activities. The amount of capital required to sustain operations is subject to future events and uncertainties, but the Company anticipates it will need to obtain approximately $2,000,000 in additional working capital in the form of debt and/or equity in order to cover our current expenses over the next 12 months in furtherance of our business plan. Whether such capital will be obtainable or obtainable on commercially reasonable terms is at this date uncertain. These circumstances raise substantial doubt about the Company’s ability to continue as a going concern.
Critical Accounting Policies
Our financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America, which require us to make estimates and judgments that significantly affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities at the date of the financial statements. Note 3, “Summary of Significant Accounting Policies” in the Notes to the Financial Statements for the year ended April 30, 2023, describes our significant accounting policies which are reviewed by management on a regular basis.
Capital Expenditures
We have not incurred any material capital expenditures.
Off-Balance Sheet Arrangements
We have not entered into any off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources and would be considered material to investors.

---

ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.
Not Applicable.

---

ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA
ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA
CROWN BAUS CAPITAL CORP.
APRIL 30, 2023, AND 2022
Report of Independent Registered Public Accounting Firm
Balance Sheets
Statements of Operations
Statements of Stockholders’ Deficit
Statements of Cash Flows
Notes to Financial Statements
Report of Independent Registered Public Accounting Firm
To: Shareholders and
Board of Directors of Crown Baus Capital Corp.
Opinion on the Financial Statements
We have audited the financial statements of Crown Baus Capital Corp. which comprise the balance sheets as of April 30, 2023 and April 30, 2022, and the related statements of operations, stockholders’ deficit, and cash flows for the years ended April 30, 2023, and April 30, 2022, and the related notes to the financial statements (collectively referred to as the "financial statements").
In our opinion, the accompanying financial statements present fairly, in all material respects, the financial position of Crown Baus Capital Corp. for the years ended April 30, 2023 and April 30, 2022, and the results of its operations and its cash flows for the two years ended April 30, 2023 in accordance with accounting principles generally accepted in the United States of America.
Substantial Doubt About the Company’s Ability to Continue as a Going Concern
The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. As discussed in Note 2 to the financial statements, the Company has a working capital deficit, and accumulated deficit for the years ended April 30, 2023 and April 30, 2022. These factors raise substantial doubt about the Company’s ability to continue as a going concern. Management’s plans in regard to these matters are also described in Note 2. The financial statements do not include adjustments that might result from the outcome of this uncertainty.
Basis for Opinion
These financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on the Company's financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) ("PCAOB") and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provides a reasonable basis for our opinion.
Critical Audit Matters
Critical audit matters are matters arising from the current period audit of the financial statements that were communicated or required to be communicated to the audit committee and that: (1) relate to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective, or complex judgments. We determined that there are no critical audit matters.
We have served as Crown Baus Capital Corp’s auditor since 2023.
PCAOB ID: 06771
We have served as Crown Baus Capital Corp’s auditor since 2023.
Houston, Texas
September 29, 2023
Crown Baus Capital Corp.
Balance Sheets
April 30, 2023, and 2022
ASSETS
Current Assets:
Cash and equivalents
$ 5,351
$ 59
Prepaid expenses
1,275
-
Total current assets
6,626
Other Assets
Investment
-
-
TOTAL ASSETS
$ 6,626
$ 59
Liabilities
Accounts payable and accrued expenses
$ 10,031
$ 91,201
Loans payable - non affiliates
220,251
200,000
Loans payable - stockholders’
17,190
67,995
Total current liabilities
247,472
359,196
Stockholders' Deficit:
Common stock, $0.001 par value; 199,920,000 and 200,000,000 shares authorized , respectively shares authorized, respectively with
161,050,000 and 161,050,000 shares issued and outstanding, respectively
161,050
161,050
Preferred Stock, $0.001 par value; 80,000 shares authorized, 0 and 0 shares issued and outstanding, respectively
-
-
Additional paid-in capital
46,675,911
46,550,000
Cancellation receivable
(21,050 )
(21,050 )
Stock subscription
7,220
-
Accumulated deficit
(47,063,977 )
(47,049,137
)
Total Stockholders' Deficit
(240,846 )
(359,137 )
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT
$ 6,626
$ 59
See accompanying notes to financial statements.
Crown Baus Capital Corp.
Statements of Operations
For the Years Ended April 30, 2023, and 2022
Revenue
$ -
$ -
Expenses:
State fees
1,300
-
Management fee
2,721
-
Professional fees
7,425
20,000
General and administrative
3,394
1,671
Total Operating expenses
14,840
21,671
Operating loss
(14,840 )
(21,671 )
Foreign exchange
-
-
Income (loss) before provision for
income taxes
(14,840 )
(21,671 )
Provision for income taxes
-
-
Net income (loss)
$ (14,840 )
$ (21,671 )
Basic and diluted loss per share
$ (0.00 )
$ (0.00 )
Basic and diluted weighted average
Number of shares outstanding
161,050,000
161,050,000
See accompanying notes to financial statements.
Crown Baus Capital Corp.
STATEMENT OF STOCKHOLDERS’ DEFICIT
For the Years Ended April 30, 2023, and 2022
Preferred Stock
Common Stock
Additional
Paid In
Cancelled
Stock
to be returned
Accumulated
Total
Stockholders’
Shares
Amount
Shares
Amount
Capital
Subscription
Deficit
Deficit
Balance, April 30, 2021
-
$ -
161,050,000
$ 161,050
$ 46,550,000
$ (21,050 )
$ (46,412,466 )
$ (337,466 )
Net loss for the year ended April 30, 2022
-
-
-
-
-
-
(21,671 )
(21,671 )
Balance, April 30, 2022
-
$ -
161,050,000
$ 161,050
$ 46,550,000
$ (21,050 )
$ (47,049,137 )
$ (359,137 )
Stock subscription
-
-
-
-
-
7,220
-
7,220
Cancellation of debt
-
-
-
-
125,911
-
-
125,911
Net Loss for the year ended April 30, 2023
-
-
-
-
-
-
(14,840 )
(14,840 )
Balance, April 30, 2023
-
$ -
161,050,000
$ 161,050
$ 46,675,911
$ (13,830 )
$ (47,063,977 )
$ (240,846 )
See accompanying notes to financial statements.
Crown Baus Capital Corp.
Statements of Cash Flows
For the Years Ended April 30, 2023, and 2022
Cash flows from operating activities:
Net income (loss)
$ (14,840 )
$ (21,671 )
Adjustments to reconcile net income (loss) to net cash used by operating activities:
Gain on debt settlement
-
-
Changes in operating assets and liabilities:
Prepaid consulting
(1,275 )
-
Accounts payable and accrued expenses
(81,171 )
16,034
Net cash used by operating activities
(97,286 )
(5,637 )
Cash flows from financing activities:
Proceeds from notes payable and subscription
27,471
-
Cancellation of debt
125,911
-
Payment on stockholders' loans
(50,804 )
4,671
Net cash provided by financing activities
102,578
4,671
Net increase (decrease) in cash
5,292
(966 )
Cash at beginning of period
1,025
Cash at end of period
$ 5,351
$ 59
Supplemental cash flow information:
Cash paid during the period for:
Interest
$ -
$ -
Income taxes
$ -
$ -
Non-cash transactions
See accompanying notes to financial statements.
CROWN BAUS CAPITAL CORP.
NOTES TO FINANCIAL STATEMENTS
NOTE 1. DESCRIPTION OF BUSINESS
Crown Baus Capital Corp. (“We” or the “Company”) was incorporated pursuant to the laws of the State of Nevada on August 8, 2011, as Flow Tech Solutions, Inc. We changed our name to World Stevia Corp. on August 15, 2013, then to Cannabis Capital Corp. on March 3, 2014, and finally to Crown Baus Capital Corp. on May 27, 2014.
Overview of Business and Operations
The Company’s mission is to work together with our shareholders, investors, and communities to create long-term value.
During the period from inception through April 30, 2017, the Company had not been successful in facilitating its various operational plans. This situation created the vast majority of operating losses and because of the issuance of shares and their market prices created the bulk of the additional paid in capital represented on the current balance sheet. From May 1, 2017 through April 2020 the Company issued shares for contractual purposes all of which have been returned for cancellation. Since current management took control in fiscal 2021there have been no new common shares issued and a new business plan has been implemented as discussed below.
Our current strategy is to identify companies in industries that complement the expertise of our management team, Board of Directors, and partners. Our management’s track record provides a highly attractive opportunity for prospective targets looking for proven value, liquidity, and capital procurement.
The Company is focused on becoming a global acquisitions-based company for being a retailer of high-end commodities either through acquisition of inventory or by sales contract with the commodity owners.
NOTE 2. BASIS OF PRESENTATION
The accompanying financial statements of the Company are presented in accordance with accounting principles generally accepted in the United States of America and with the requirements for Form 10-K and Regulation S-X.
Going Concern
Since inception, the Company has had an accumulated deficit of $47,063,977. The Company currently has only limited working capital with which to continue its operating activities. The amount of capital required to sustain operations is subject to future events and uncertainties. The Company must secure additional working capital through loans, sale of equity securities, or a combination, in order to implement its current business plans. There can be no assurance that such funding will be available in the future, or available on commercially reasonable terms favorable to the Company. These conditions raise substantial doubt about the Company's ability to continue as a going concern.
The accompanying financial statements have been presented on the basis of the continuation of the Company as a going concern and do not include any adjustments relating to the recoverability and classification of recorded asset amounts or the amounts and classifications of liabilities that might be necessary should the Company be unable to continue as a going concern. Management continued to manage its costs for the year ended April 30, 2023, to ensure appropriate funding is on hand for its limited operations.
NOTE 3. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Principles of Consolidation
The financial statements include the accounts of the Company. The Company did not have operations for the year ended April 30, 2023, or 2022.
Use of Estimates
The preparation of financial statements in conformity with United States generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The Company regularly evaluates estimates and assumptions related to intangible assets and deferred income tax asset valuation allowances. The Company bases its estimates and assumptions on current facts, historical experience, and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. The actual results experienced by the Company may differ materially and adversely from the Company’s estimates. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected.
Impairment of Long-Lived Intangible Assets
We review our long-lived assets, including intangible assets subject to amortization, for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Impairment, if any, is measured as the excess of the carrying amount over the fair value based on market value (when available) or discounted expected cash flows of those assets and is recorded in the period in which the determination is made. Intangible assets not subject to amortization are tested annually for impairment and more frequently if events or changes in circumstances indicate that it is more likely than not that the asset is impaired.
Cash
Cash includes all highly liquid instruments with an original maturity of three months or less at the date of purchase. The Company maintains its cash in cash deposit accounts, which are insured by the Federal Deposit Insurance Corporation (FDIC) up to $250,000 per legal ownership. At times, the Company’s accounts may exceed federally insured limits. To date, the Company has not experienced any losses in such accounts. On April 30, 2022, and 2023, the Company had $59 and $5,351 in cash and no other cash equivalents, respectively.
Fair Value of Financial Instruments
The Company’s financial instruments consist of cash, accounts payable, accrued liabilities, line of credit payable, loans from a related party, contingent consideration payable, and convertible note payable. The carrying amount of these financial instruments approximates fair value due either to length of maturity or interest rates that approximate prevailing market rates unless otherwise disclosed in these financial statements.
Derivative Financial Instruments
The Company reviews the terms of convertible debt, equity instruments and other financing arrangements to determine whether there are embedded derivative instruments, including embedded conversion options that are required to be bifurcated and accounted for separately as a derivative financial instrument. Also, in connection with the issuance of financing instruments, the Company may issue freestanding options or warrants that may, depending on their terms, be accounted for as derivative instrument liabilities, rather than as equity. The Company may also issue options or warrants to non-employees in connection with consulting or other services.
Derivative financial instruments are initially measured at their fair value. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported as charges or credits to income. For warrant-based derivative financial instruments, the Company used the Black-Scholes option pricing model to value the derivative instruments. The Binomial Lattice Model may be used to provide a model that the Company believes provides a more representative model of future expenses, conversion periods and length of time to conversion than the Black Scholes based upon only the remaining short time to note maturities all existing notes have embedded conversion features that cause all of the following accounting treatments to be utilized. To the extent that the initial fair values of the freestanding and/or bifurcated derivative instrument liabilities exceed the total proceeds received, an immediate charge to income is recognized, in order to initially record the derivative instrument liabilities at their fair value.
The discount from the face value of the convertible debt or equity instruments resulting from allocating some or all of the proceeds to the derivative instruments, together with the stated interest on the instrument, is amortized over the life of the instrument through periodic charges to income, usually using the effective interest method.
The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is reassessed at the end of each reporting period. If reclassification is required, the fair value of the derivative instrument, as of the determination date, is reclassified. Any previous charges or credits to income for changes in the fair value of the derivative instrument are not reversed. Derivative instrument liabilities are classified in the balance sheet as current or non-current based on whether or not net-cash settlement of the derivative instrument could be required within twelve months of the balance sheet date.
Revenue Recognition
In May 2014, the FASB issued ASU 2014-09, Revenue from Contracts with Customers (“ASU 2014-09”) and Accounting Standards Codification (“ASC”) Subtopic 340-40, Other Assets and Deferred Costs - Contracts with Customers (“ASC 340-40”), (collectively, “Topic 606”). On January 1, 2019, the Company adopted Topic 606. ASU 2014-09 requires entities to recognize revenue through the application of a five-step model, which includes identification of the contract, identification of the performance obligations, determination of the transaction price, allocation of the transaction price to the performance obligations and recognition of revenue as the entity satisfies the performance obligations. The Company implemented ASU 2014-09 for the interim and annual reporting periods of 2015 through 2023, which resulted in no changes to our financial statements as there is no revenue reported in the years presented.
Business Combinations
Each investment in a business is being measured and determined whether the investment should be accounted for as a cost-basis investment, an equity investment, a business combination, or a common control transaction. An investment in which the Company do not have a controlling interest and which the Company is not the primary beneficiary but where the Company has the ability to exert significant influence is accounted for under the equity method of accounting. For those investments that we account for in accordance ASC 805, Business Combinations, the Company records the assets acquired and liabilities assumed at the management’s estimate of their fair values on the date of the business combination. The assessment of the estimated fair value of each of these can have a material effect on the reported results as intangible assets are amortized over various lives. Furthermore, according to ASC 805-50-30-5, when accounting for a transfer of assets or exchange of shares between entities under common control, the entity that receives the net assets or the equity interests shall initially measure the recognized assets and liabilities transferred at their carrying amounts in the accounts of the transferring entity at the date of transfer.
Net Income (Loss) Per Common Share
Basic loss per common share (“EPS”) is calculated by dividing the net loss available to common shareholders by the weighted average number of common shares outstanding for the period. Diluted EPS reflects the potential dilution that could occur if securities or other contracts to issue common stock were exercised or converted into common stock. The number of common shares that are exercisable from warrants or converted from debt into common stock is material to affect diluted EPS results.
Stock-Based Compensation
On August 8, 2011, the Company adopted the fair value recognition provisions codified in ASC 718, Compensation-Stock Compensation. The Company adopted those provisions using the modified-prospective-transition method. Under this method, compensation cost recognized for all periods prior to April 30, 2012, includes a) compensation cost for all share-based payments granted prior to, but not yet vested as of November 30, 2005, based on the grant-date fair value and b) compensation cost for all share-based payments granted subsequent to November 30, 2005, based on the grant-date fair value. In addition, deferred stock compensation related to non-vested options is required to be eliminated against additional paid-in capital. The results for periods prior to April 30, 2012, were not restated.
The Company accounts for equity instruments issued in exchange for the receipt of goods or services from parties other than employees in accordance with ASC 505, Equity. Costs are measured at the estimated fair market value of the consideration received or the estimated fair value of the equity instruments issued, whichever is more reliably measurable. The value of equity instruments issued for consideration other than employee services is determined at the earliest of a performance commitment or completion of performance by the counterparty. There are no stock based compensation commitments in existence at, April 30, 2023.
Income Taxes
Potential benefits of income tax losses are not recognized in the accounts until realization is more likely than not. The Company has adopted the accounting standards codified in ASC 740, Income Taxes as of its inception. Pursuant to those standards, the Company is required to compute tax asset benefits for net operating losses carried forward. The potential benefit of net operating losses has not been recognized in these financial statements because the Company cannot be assured it is more likely than not that it will utilize the net operating losses carried forward in future years.
ASC 740-10-25 prescribes recognition thresholds that must be met before a tax position is recognized in the financial statements and provides guidance on de-recognition, classification, interest and penalties, accounting in interim periods, disclosure, and transition. An entity may only recognize or continue to recognize tax positions that meet a “more likely than not” threshold. Based on its evaluation, the Company has concluded that there are no significant uncertain tax positions requiring recognition in its financial statements.
The Company does not have any unrecognized tax benefits as of April 30, 2022, and 2023 that, if recognized, would affect the Company’s effective income tax rate. The Company’s policy is to recognize interest and penalties related to income tax issues as components of income tax expense. The Company did not recognize or have any accrual for interest and penalties relating to income taxes as of April 30, 2022, and 2023 .
Common Share Non-Monetary Consideration
In situations where common shares are issued and the fair value of the goods or services received is not readily determinable, the fair value of the common shares is used to measure and record the transaction. The fair value of the common shares issued in exchange for the receipt of goods and services is based on the stock price as of the earliest of the date at which:
i.
The counterparty’s performance is complete;
ii.
commitment for performance by the counterparty to earn the common shares is reached; or
iii.
the common shares are issued if they are fully vested and non-forfeitable at that date.
Share Purchase Warrants
The Company accounts for common share purchase warrants at fair value in accordance with ASC 815, “Derivatives and Hedging”. The Black-Scholes option pricing valuation method is used to determine the fair value of these warrants. The use of this method requires that the Company make assumptions regarding stock volatility, dividend yields, expected term of the warrants and risk-free interest rates.
Convertible Instruments
The Company evaluates and accounts for conversion options embedded in convertible instruments in accordance with ASC 815 “Derivatives and Hedging Activities”. Applicable GAAP requires companies to bifurcate conversion options from their host instruments and account for them as free-standing derivative financial instruments according to certain criteria. The criteria include circumstances in which (a) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract, (b) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not re-measured at fair value under other GAAP with changes in fair value reported in earnings as they occur and (c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument. Each reporting period, the Company evaluates whether convertible debt to acquire stock of the Company contain provisions that protect holders from declines in the stock price or otherwise could result in modification of the exercise price under the respective convertible debt agreements.
The Company accounts for convertible instruments (when we have determined that the embedded conversion options should not be bifurcated from their host instruments) as follows: The Company records when necessary, discounts to convertible notes for the intrinsic value of conversion options embedded in debt instruments based upon the differences between the fair value of the underlying common stock at the commitment date of the note transaction and the effective conversion price embedded in the note. Debt discounts under these arrangements are amortized over the term of the related debt to their stated date of redemption. The Company uses a Binomial Lattice Model to judge the fair value of all of its currently outstanding derivative liabilities and to amortize any debt discounts that may have a remaining balance.
Risks and Uncertainties
The Company is not able to predict the ultimate impact political and health concerns will have on its business; however, if the current economic conditions continue, the Company will be forced to significantly scale back its business operations and its growth plans and could ultimately have a significant negative impact on the Company.
Recently and Issued Accounting Pronouncements
Management has considered all recent accounting pronouncements issued since the last audit of our financial statements. The Company’s management believes that these recent pronouncements will not have a material effect on the Company’s financial statements.
NOTE 4. RELATED PARTY TRANSACTIONS
During the year ended April 30, 2023, a stockholder of the Company loaned the Company $0 to pay for certain expenses. Total loans payable to stockholders, on April 30, 2023, and 2022, totaled $17,190 and $67,995, respectively. The loans bear no interest and are payable on demand.
Management Agreements
For the years ended April 30, 2023, the following executive compensation was recorded:
None.
NOTE 5. LOANS PAYABLE
During the year ended April 30, 2023, the Company issued a note payable for cash of $20,251. The note is payable on demand and will cost 100,000 common shares when paid plus the cash basis.
NOTE 6. STOCKHOLDERS' DEFICIT
Authorized
The Company is authorized to issue 199,920,000 shares of common stock, having a par value of $0.001 per share.
Issued and Outstanding
In February 2012, the Company issued 25,000,000 shares of common stock at par value of $0.001.
On August 15, 2013, the Company did a 5:1 forward split of its common stock bringing the issued and outstanding common stock to 125,000,000.
During February 2014, the Company issued 15,000,000 shares of its common stock with a fair market value of $45,000,000, as bonuses pursuant to the terms of three management agreements with officer's and stockholders for management services rendered to the Company.
For the year ended April 30, 2014, the Company issued 2,200,000 shares of the Company's common stock with a fair market value of $40,788,000 to certain consultants, pursuant to the terms of their consulting agreements, for services to be provided in future periods. For the year ended April 30, 2014, $322,037 had been expensed. This contract was cancelled in 2015 and the consulting charge reversed. The shares have not been recovered.
On June 24, 2014, the Company entered into a Property Purchase Agreement to acquire properties in Washington State and California for business operations. A total of $200,000 in deposits were paid towards to acquisition of the properties in addition to issued 100,000 Rule 144 restricted shares of common stock with a fair market value of $1,250,000. The agreement was cancelled on October 24, 2014. No charges were taken except that the common shares were issued and as of the date of this filing have not been recovered.
On June 24, 2014, the Company entered into a five-year Consulting Agreement with a consultant to perform services related to acquiring properties in Washington, Nevada, Colorado, and California in addition to managing them for the Company in exchange for 1,150,000 Rule 144 restricted shares of common stock with a fair market value of $14,375,000. This project was cancelled in 2015. No charges were taken except that the common shares were issued and as of the date of this filing have not been recovered.
On May 1, 2014, the Company closed the acquisition of WebCongress, Inc., a Nevada corporation and Miami based technology, education, and consulting company. Pursuant to the April 15, 2014, Share Purchase Agreement, the Company issued 100,000 Rule 144 Restricted shares of common stock with a fair market value of $1,854,000 or $18.54 per share to the principals, to acquire WebCongress. The Company also committed to funding a total of $3,000,000 to cover operating costs over three years. This contract was cancelled in 2015 and the stock has been returned but not cancelled.
On September 14, 2016, the Company hired Ben Tam as CFO and agreed to issue 2,500,000 shares of common stock for services. The shares were not issued and valued at the price on the employment date of $0.42, or $1,050,000. The shares were issued on January 11, 2018. The Company recognized $1,050,000 in stock-based compensation during the year ended April 30, 2017. The Company terminated the agreement in January 2020 for non-performance. The shares have not been recovered.
On September 28, 2016, the Company agreed to acquire Aeonik, Inc. for 15,000,000 shares of common stock. The shares were not issued and valued at the market price of $0.42, or $6,300,000. The shares were issued on January 11, 2018. The acquisition was terminated on January 15, 2018. The shares have not been recovered.
On March 20, 2023, the Company authorized 80,000 Series A Convertible Preferred shares for the purchase of a commodity. The shares will be released when the State of Nevada has stamped the Stock Designation amendment.
The Company has not issued any warrants or stock options.
NOTE 7. INCOME TAXES
Potential benefits of income tax losses and other tax assets are not recognized in the accounts until realization is more likely than not. As of April 30, 2023, the Company has operating loss carry forwards of approximately $46,444,389 for tax purposes in various jurisdictions subject to expiration as described below. Pursuant to ASC 740, Income Taxes, the Company is required to compute tax asset benefits for net operating losses carried forward and other items giving rise to deferred tax assets. Future tax benefits which may arise as a result of these losses and other items have not been recognized in these financial statements, as their realization is determined not likely to occur and accordingly, the Company has recorded a valuation allowance for the deferred tax asset relating to these items.
The actual income tax provisions differ from the expected amounts calculated by applying the combined income tax statutory rates applicable in each jurisdiction to the Company’s loss before income taxes and non-controlling interest. The calculated tax deferred benefit on April 30, 2023, and 2022 is based on the current Federal statutory income tax rate of 21% applied to the loss before provision for income taxes.
The following table accounts for the differences between the actual income tax benefit and amounts computed for the years ended April 30, 2023, and 2022:
Years Ended
April 30,
Tax benefit at the federal statutory rate
$ 47,063,977
$ 47,049,137
Non-deductible costs
-
-
Decrease in valuation allowance
(47,063,977 )
(47,049,137 )
Income tax expense
$ -
$ -
The components of the deferred tax asset and deferred tax liability on April 30, 2023, and 2022 are as follows:
April 30,
Deferred tax assets
$ 9,883,435
9,880,318
Valuation allowance
(9,883,435 )
(9,880,318 )
A valuation allowance has been provided to reduce the net deferred tax asset, as management determined that it is more likely than not that the deferred tax assets will not be realized.
On April 30, 2023, the Company has approximately a net operating loss carry forward for United States income tax purposes approximating $47,063,977. These losses expire in varying amounts between April 30, 2033, and 2043.
NOTE 8. BASIS OF REPORTING
The Company's financial statements are presented on a going concern basis, which contemplates the realization of assets and satisfaction of liabilities in the normal course of business.
The Company has experienced a loss as a result of the investment necessary to achieve its operating plan, which is long-range in nature. For the period ending April 30, 2023, the Company incurred a net loss of approximately $47,063,977 In addition, the Company has no significant assets or revenue generating operations at, April 30, 2023.
The Company currently does not have sufficient cash to sustain itself for the next 12 months and will require additional funding in order to execute its plan of operations and to continue as a going concern. To meet its cash needs, management expects to raise capital through a private placement offering. In the event that this funding does not materialize, certain stockholders have agreed, orally, to loan, on a non-interest-bearing demand basis, sufficient funds to maintain the Company's operations for the next 12 months.
The financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classification of liabilities that may result from the possible inability of the Company to continue as a going concern.
NOTE 9. FAIR VALUE MEASUREMENT
The Company values its derivative instruments under FASB ASC 820 which defines fair value, establishes a framework for measuring fair value, and expands disclosures about fair value measurements.
Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date (exit price). The Company utilizes market data or assumptions that market participants would use in pricing the asset or liability, including assumptions about risk and the risks inherent in the inputs to the valuation technique. These inputs can be readily observable, market corroborated, or generally unobservable. The Company classifies fair value balances based on the observability of those inputs. ASC 820 establishes a fair value hierarchy that prioritizes the inputs used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (level 1 measurement) and the lowest priority to unobservable inputs (level 3 measurement).
The three levels of the fair value hierarchy are as follows:
Level 1 - Quoted prices are available in active markets for identical assets or liabilities as of the reporting date. Active markets are those in which transactions for the asset or liability occur in sufficient frequency and volume to provide pricing information on an ongoing basis. Level 1 primarily consists of financial instruments such as exchange-traded derivatives, marketable securities, and listed equities.
Level 2 - Pricing inputs are other than quoted prices in active markets included in level 1, which are either directly or indirectly observable as of the reported date.
Level 3 - Pricing inputs include significant inputs that are generally less observable from objective sources. These inputs may be used with internally developed methodologies that result in management’s best estimate of fair value.
The Company’s financial instruments consisted of cash, prepaid expenses, deposit, accounts payable and accrued liabilities, line of credit, loan from stockholders and convertible debt. The estimated fair value of cash, prepaid expenses, deposit, accounts payable and accrued liabilities, line of credit, loan from stockholders approximates its carrying amount due to the short maturity of these instruments. The recognition of the derivative values of convertible debt are based on the weighted-average Black-Scholes option pricing model, which the Company’s classifies as a level three of the fair value measurement hierarchy.
The derivative liabilities are measured at fair value using quoted market prices and estimated volatility factors based on historical quoted market prices for the Company’s common stock and are classified within Level 3 of the valuation hierarchy.
NOTE 10. SUBSEQUENT EVENTS
None.

---

ITEM 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS
ITEM 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS
There have been no occurrences requiring response to this item.

---

ITEM 9A. CONTROLS AND PROCEDURES
ITEM 9A. CONTROLS AND PROCEDURES
Evaluation of Disclosure Controls and Procedures
The Company’s management, with the participation of the Company’s Chief Executive Officer and Chief Financial Officer, has evaluated the effectiveness of the Company’s disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) as of the end of the period covered by this report. Based on such evaluation, the Company’s Chief Executive Officer and Chief Financial Officer have concluded that, as of the end of such period, the Company’s disclosure controls and procedures were not effective as of the end of the period covered by this report. This conclusion is based on the findings discussed below, that constituted a material weakness. A material weakness is a deficiency, or a combination of control deficiencies, in internal control over financial reporting such that there is a reasonable possibility that a material misstatement of the Company’s interim financial statements will not be prevented or detected on a timely basis.
Management’s Report on Internal Control over Financial Reporting
The Company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of the company’s assets that could have a material effect on the financial statements.
In performing the above-referenced assessment, management had concluded that as of April 30, 2023, there were deficiencies in the design or operation of our internal control that adversely affected our internal controls which management considers to be material weakness including those described below:
Lack of Formal Policies and Procedures. The Company utilizes a third-party independent contractor for the preparation of its financial statements. Although the financial statements and footnotes are reviewed by our management, we do not have a formal policy to review significant accounting transactions and the accounting treatment of such transactions. The third-party independent contractor is not involved in the day-to-day operations of the Company and may not be provided with information from management on a timely basis to allow for adequate reporting/consideration of certain transactions.
Because of its inherent limitations, internal control over financial reporting is not intended to provide absolute assurance that a misstatement of our financial statements will be prevented or detected. Also, projections of any evaluation of effectiveness to future periods are subject to the risks that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.
Management conducted an evaluation of the effectiveness, as of April 30, 2023, of our internal control over financial reporting based on criteria established in Internal Control - Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO) updated 2013. Based on this evaluation, management concluded that the Company’s internal control over financial reporting was effective as of April 30, 2023.
Management of the Company is responsible for establishing and maintaining adequate internal control over financial reporting as defined in Rules 13a15(f) and 15d15(f) under the Exchange Act. The Company's internal control over financial reporting is designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with GAAP. The Company's internal control over financial reporting includes those policies and procedures that:
•
pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the Company;
•
provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with GAAP, and that receipts and expenditures of the Company are being made only in accordance with authorizations of management and directors of the Company; and
•
provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of the Company’s assets that could have a material effect on the financial statements.
Changes in Internal Control over Financial Reporting
During the year ended April 30, 2023, there were no changes in our internal control over financial reporting identified in connection with management’s evaluation of the effectiveness of our internal control over the financial reporting that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act.
Independent Registered Accountant’s Internal Control Attestation
This annual report does not include an attestation report of the Company’s registered public accounting firm regarding internal control over financial reporting. On July 21, 2010, President Obama signed into law the Dodd-Frank Wall Street Reform and Consumer Protection Act, which permanently exempts smaller reporting companies from providing attestation of their internal controls pursuant to Section 404 of the Sarbanes-Oxley Act. As a result, this report does not provide such an attestation, and the Company will be exempted from providing such an attestation until such time as it reaches $75 million in market capitalization.

---

ITEM 9B. OTHER INFORMATION
ITEM 9B. OTHER INFORMATION
There is no information to be disclosed in a report on Form 8-K during the fourth quarter of the fiscal year covered by this Form 10-K that has not been previously filed with the Securities and Exchange Commission.
PART III

---

ITEM 10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE
ITEM 10. DIRECTORS, EXECUTIVE OFFICERS, AND CORPORATE GOVERNANCE
Our Directors and Executive Officers
Set forth below is certain information with respect to our executive officers and directors. Our directors are generally elected at the annual shareholders’ meeting and hold office until the next annual shareholders’ meeting and until their successors are elected and qualify. Executive officers are elected by our board of directors and serve at its discretion. Our bylaws provide that the board of directors shall consist of at least one member, but the number may be increased, or decreased to not less than one, from time to time, either by the directors by adoption of a resolution to such effect or by the stockholders by amendment of the By Laws. Our board of directors currently consists of three members. The names and ages of the directors and executive officers of the Company, and their positions with the Company, are as follows:
Name
Age
Position
Charles Kwon
Director
Andy Jagpal
CEO, CFO, President, and Director
The term of office of each director expires at our annual meeting of stockholders or until their successors are duly elected and qualified. Directors are not compensated for serving as such. Officers serve at the discretion of the Board of Directors.
Biographies of Chairman, Officers and Directors
Charles J.S. Kwon
Director
Mr. Kwon received his Business Diploma from the British Columbia Institute of Technology in 2002. Afterwards, he started his career in the capital markets as a trader. Then in 2006, as an Investment Advisor at Global Securities. For the past 5 years, Mr. Kwon has been a partner at ReThink, managing their Real Estate and Investment holdings. Mr. Kwon melds his experience in the capital market sector with business expertise, inspirational vision, fundraising experience, and strategic focus.
Mr. Kwon will serve as a Company director and officer until his duly elected successor is appointed or his resignation. There are no arrangements or understandings between Mr. Kwon any other person pursuant to which he was selected as an officer or director. There are no family relationships between Mr. Kwon and any of the Company’s officers or directors. Mr. Kwon has not held any other directorships in a company with a class of securities registered pursuant to section 12 of the Exchange Act or subject to the requirements of section 15(d) of such Act or any company registered as an investment company under the Investment Company Act of 1940 during the past 5 years.
Andy Jagpal
CEO, CFO, President, and Director
Mr. Jagpal holds a Bachelor of Science from the University of British Columbia and was a research assistant with the Dean of Plant Science and Agriculture Canada. As an entrepreneur, Mr. Jagpal was the President of Alliance Vancouver, an Executive Office Business Center that assisted new start-up companies and existing high growth companies with their back-office and day to day business management including telephone and reception service, administrative services, bookkeeping and staff resourcing. Over 100 companies were supported by Alliance Vancouver in their downtown Vancouver locations. Mr. Jagpal has also been involved with taking emerging companies public and providing access to venture capital along with mergers and acquisition support. Mr. Jagpal has also participated in the startup of mining projects in Philippines and Peru. Currently Mr. Jagpal serves as President of Primo Nutraceuticals, a company listed on the Canadian Securities Exchange. Primo is involved in producing and marketing nutraceutical products for the health and wellness marketplace.
Significant Employees
None.
Family Relationships
None.
Involvement in Certain Legal Proceedings
No officers or directors has been involved in any of the following events within the last ten years that is material to an evaluation of their ability or integrity as described in Item 401(f) of Regulation S-K.
Board Committees
Nominating and Compensation Committees
The Company does not have standing nominating or compensation committees, or committees performing similar functions. The Company's Board of Directors believes that it is not necessary to have a compensation committee at this time because the functions of such a committee are adequately performed by the Board of Directors. The Board of Directors is also of the view that it is appropriate for the Company not to have a standing nominating committee because the Board of Directors has performed and will perform adequately the functions of a nominating committee.
The Company does not have any restrictions on shareholder nominations under its certificate of incorporation or by-laws. The only restrictions are those applicable generally under Nevada corporate law and the federal proxy rules, The Board of Directors will consider suggestions from individual shareholders, subject to evaluation of the person's merits. Stockholders may communicate nominee suggestions directly to the Board of Directors, accompanied by biographical details and a statement of support for the nominees. The suggested nominee must also provide a statement of consent to being considered for nomination. There are no formal criteria for nominees at the present time.
Audit Committee and Audit Committee Financial Expert
We are not required to, and we do not have an Audit Committee. The Company's directors perform some of the same functions of an Audit Committee, such as: recommending a firm of independent certified public accountants to audit the financial statements; reviewing the auditors' independence, the financial statements, and their audit report; and reviewing management's administration of the system of internal accounting controls. The Company does not currently have a written audit committee charter or similar document.
We have no “audit committee financial expert” as defined in Item 407(d)(5)(ii) of Regulation S-K. Our directors have financial statement preparation and interpretation ability obtained over the years from past business experience and education. We believe the cost related to retaining a financial expert at this time is prohibitive. Further, because of the nature of our current limited operations, we believe the services of a financial expert are not warranted.
Code of Ethics
The Company’s Board of Directors is developing a code of ethics (the “Code”) that will apply to members of the Board of Directors, all officers, employees and contemplated directors, officers, and employees. The Code will set forth written standards that are designed to deter wrongdoing and to promote:
●
honest and ethical conduct,
●
full, fair, accurate, timely, and understandable disclosure in reports and documents that we file with, or submit to, the Securities and Exchange Commission and in other public communications made by us;
●
compliance with applicable governmental laws, rules, and regulations;
●
prompt internal reporting of violations of the Code to an appropriate person or persons identified in the Code; and
●
accountability for adherence to the Code.
An official Code of Ethics has been finalized by the Board of Directors and made available upon request by a shareholder of the Company. We will describe the nature of amendments to the Code on our website, except that we may not describe amendments that are purely technical, administrative, or otherwise non-substantive. We will also disclose on our website any waivers from any provision of the Code that we may grant. Information about amendments and waivers to the Code will be available on our website for at least 12 months, and thereafter, the information will be available upon request for five years.
Conflicts of Interest
Certain conflicts of interest exist and may continue to exist between the Company and its officers and directors due to the fact that each has other business interests to which they devote their primary attention. Each officer and director may continue to do so notwithstanding the fact that management time should be devoted to the business of the Company.
Certain conflicts of interest may exist between the Company and its management, and conflicts may develop in the future. The Company has not established policies or procedures for the resolution of current or potential conflicts of interest between the Company, its officers and directors or affiliated entities. There can be no assurance that management will resolve all conflicts of interest in favor of the Company, and conflicts of interest may arise that can be resolved only through the exercise by management their best judgment as may be consistent with their fiduciary duties. Management will try to resolve conflicts to the best advantage of all concerned.
Shareholder Communications
The Company provides access for its shareholders to the Company via telephone and its web site, www.elitedata.io. Shareholders are able to, and encouraged to, view all of the Company’s SEC filings as well as gain knowledge about the Company’s activities and developments that affect the shareholder’s relationship with the Company. The Company has retained the services of a dedicated professional that provides functions related to the development and distribution of shareholder communications.
SECTION 16(a) BENEFICIAL OWNERSHIP REPORTING COMPLIANCE
Section 16(a) of the Securities Exchange Act of 1934, as amended, requires our directors and executive officers and the holders of more than 10% of our common stock to file with the Securities and Exchange Commission initial reports of ownership and reports of changes in ownership of our equity securities. Based solely on our review of the copies of the forms received by us and written representations from certain reporting persons, we believe that, during the year ended April 30, 2012, all of our executive officers, directors, and the holders of 10% or more of our Common Stock had not complied with all Section 16(a) filing requirements.

---

ITEM 11. EXECUTIVE COMPENSATION
ITEM 11. EXECUTIVE COMPENSATION
Compensation Discussion and Analysis
The Company is not a "listed company" under SEC rules and is therefore not required to have a compensation committee. Accordingly, the Company has no compensation committee.
Except as set forth in the summary compensation table below, during the fiscal years ended April 30, 2019, and 2021, the Company has not provided any salary, bonus, annual or long-term equity or non-equity based incentive programs, health benefits, life insurance, tax-qualified savings plans, special employee benefits or perquisites, supplemental life insurance benefits, pension or other retirement benefits or any type of nonqualified deferred compensation programs for its executive officers or employees.
No retirement, pension, profit sharing, stock option or insurance programs or other similar programs are currently in existence.
There are no understandings or agreements regarding compensation our management will receive after a business combination that is required to be included in this table, or otherwise.
The following table shows the compensation accrued during the years ended April 30, 2023, and 2022 to the Company's executive officers.
SUMMARY COMPENSATION TABLE
Name and Principal Position
Year
Salary
Bonus
Warrant Awards
All Other Compensation
Total
Charles Kwon
$ -
$ -
$ -
$ -
$ -
President and Director
-
-
-
-
-
Andy Jagpal
$ -
$ -
$ -
$ -
$ -
CEO, CFO, President and Director
-
-
-
-
-
Employment Agreements
None.
Compensation of Directors
During the fiscal years ended April 30, 2022, and 2023, respectively, except as set forth above.

---

ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS
ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGED AND RELATED STOCKHOLDER MATTERS
The following table sets forth certain information regarding the Company's common stock beneficially owned on April 30, 2023, for (i) each shareholder the Company knows to be the beneficial owner of 5% or more of its outstanding common stock, (ii) each of the Company's executive officers and directors, and (iii) all executive officers and directors as a group. In general, a person is deemed to be a "beneficial owner" of a security if that person has or shares the power to vote or direct the voting of such security, or the power to dispose or to direct the disposition of such security. A person is also deemed to be a beneficial owner of any securities of which the person has the right to acquire beneficial ownership within 60 days. To the best of the Company's knowledge, all the people named have sole voting and investment power with respect to such shares, except as otherwise noted. On April 30, 2023, 161,050,000 shares of the Company's common stock were outstanding.
Name of Person or Group
Number of Shares
of Common Stock Owned
Percentage of Ownership
Charles J.S. Kwon
-
-
Andy Jagpal
80,000,000
49.67 %
All executive officers and directors as a group (three persons)
80,000,000
49.67 %
___________________
The Company has no securities authorized for issuance under equity compensation plans.

---

ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS
ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE
Except as otherwise indicated herein, there have been no related party transactions, or any other transactions or relationships required to be disclosed pursuant to Item 404.

---

ITEM 14. PRINCIPAL ACCOUNTING FEES AND SERVICES
ITEM 14. PRINCIPAL ACCOUNTANT FEES AND SERVICES
Audit Fees
The aggregate fees billed by Victor Mokuolu, CPA PLLC for our annual financial statements and review of financial statements included in our quarterly reports or services that are normally provided in connection with statutory and regulatory filings were $8,000 for the year ended April 30, 2023.
Tax Fees
The Company incurred $0 expenses for professional services for tax compliance, tax advice, and tax planning for the fiscal year ended April 30, 2023, and $0 expenses for year ended April 30, 2022.
Policy on Audit Committee Pre-Approval of Audit and Permissible Non-audit Services of Independent Auditors
The Board of Directors acts as the audit committee of the Company, and accordingly, all services are approved by all the members of the Board of Directors.

---

ITEM 15. EXHIBITS, FINANCIAL STATEMENT SCHEDULES
ITEM 15. SUBSEQUENT EVENT
For the year ended April 30, 2023, the company issued 1,000 shares of the Company’s preferred stock for the acquisition of certain assets valued at $48,000,000 with the remainder in a note payable of $47,999,999. This acquisition will close upon the filing of this document in August 2023.
PART IV